NCT05660395
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05660395
Title A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BRA

Facility Status City State Zip Country Details
The Oncology Institute of Hope & Innovation - Lynwood Lynwood California 90262 United States Details
Hospital Sírio-Libanês - Brasília Brasília 70200-730 Brazil Details
Hospital Mãe de Deus - Centro Integrado de Oncologia Porto Alegre 90110-270 Brazil Details
Hospital Sírio-Libanês - São Paulo São Paulo 01308-050 Brazil Details
A Beneficência Portuguesa de São Paulo - Unidade Mirant São Paulo 01323-030 Brazil Details
Hospital 9 de Julho São Paulo 01409-002 Brazil Details
Albert Einstein Israelite Hospital São Paulo 05652-900 Brazil Details
Kyungpook National University Chilgok Hospital Daegu Daegu Gwang'yeogsi 41944 South Korea Details
Dong-A University Hospital Pusan Gyeongsangnam-do 602-812 South Korea Details
Korea University Anam Hospital Seoul Seongbuk District 02841 South Korea Details
Seoul National University Hospital Seoul Seoul Teugbyeolsi [Seoul-T'ukpyolshi] 03080 South Korea Details
Severance Hospital Seoul Seoul Teugbyeolsi 03722 South Korea Details
National Taiwan University Hospital Taipei 100 Taiwan Details
Koo Foundation Sun Yat-Sen Cancer Center Taipei Taiwan 112 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field